| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $12.77 ▲ +1.86% | Yesterday | $12.44 ▼ -0.78% | Tomorrow's Artiva Biotherapeutics Inc. Common Stock (ARTV) setup is anchored to $12.54 and targets $12.77 (+1.86%). The near-term read is upside; watch $12.92 / $12.16 because daily realized volatility is about 8.00%. |
Tomorrow's Artiva Biotherapeutics Inc. Common Stock (ARTV) setup is anchored to $12.54 and targets $12.77 (+1.86%). The near-term read is upside; watch $12.92 / $12.16 because daily realized volatility is about 8.00%. | ||||
| Week | $13.26 ▲ +5.77% | Last Week | $12.24 ▼ -2.43% | The 7-day Artiva Biotherapeutics Inc. Common Stock model moves from $12.24 to $13.26 (+5.77%). It gives upside momentum context for this stock, so breaks around $12.92 / $12.16 matter more than a single tick. |
The 7-day Artiva Biotherapeutics Inc. Common Stock model moves from $12.24 to $13.26 (+5.77%). It gives upside momentum context for this stock, so breaks around $12.92 / $12.16 matter more than a single tick. | ||||
| Month | $14.08 ▲ +12.30% | Last Month | $11.89 ▼ -5.17% | The 1-month Artiva Biotherapeutics Inc. Common Stock target is $14.08 (+12.30%), compared with the live reference near $12.54. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Artiva Biotherapeutics Inc. Common Stock target is $14.08 (+12.30%), compared with the live reference near $12.54. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $15.31 ▲ +22.08% | Last Year | $11.38 ▼ -9.27% | The 1-year Artiva Biotherapeutics Inc. Common Stock scenario points to $15.31 (+22.08%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Artiva Biotherapeutics Inc. Common Stock scenario points to $15.31 (+22.08%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $18.18 ▲ +45.00% | 5 Years Ago | $10.17 ▼ -18.90% | The 5-year Artiva Biotherapeutics Inc. Common Stock view is $18.18 (+45.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Artiva Biotherapeutics Inc. Common Stock view is $18.18 (+45.00%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $12.54 | Mid |
| Daily Change | -6.35% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 71% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $12.54 | Daily Change | -6.35% |
| Market Cap | $309.95M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.